导管消融术改善心房颤动患者肾功能受损的研究进展
Research Advances of Catheter Ablation Improving Renal Function Impairment in Patients with Atrial Fibrillation
DOI: 10.12677/acm.2024.1492526, PDF,    科研立项经费支持
作者: 陈小玲, 李传伟*：重庆市急救医疗中心(重庆大学附属中心医院)心内科，重庆
关键词: 心房颤动；导管消融术；慢性肾脏病；Atrial Fibrillation； Catheter Ablation； Chronic Kidney Disease
摘要: 心房颤动(Atrial fibrillation, AF)是最常见的持续性心律失常，慢性房颤可通过各种机制引起肾功能损伤，导致或加重慢性肾脏病(chronic kidney disease, CKD)。而CKD患者也常合并AF，二者之间有着密切的相关性。目前导管消融术已成为AF的一线治疗，在维持窦性心律、改善预后等方面较药物治疗更优。已有研究证实AF导管消融术后部分患者肾功能得到显著改善，但其中具体的关系尚不明确。本文就AF与CKD之间复杂的病理生理学相关性及AF导管消融延缓肾功能衰退的相关研究进行文献综述。
Abstract: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Chronic AF, through various pathophysiological mechanisms, can adversely affect renal function, leading to the initiation or exacerbation of chronic kidney disease (CKD). The bidirectional relationship between CKD and AF is well-documented, with both conditions frequently coexisting. Presently, catheter ablation (CA) is considered the first-line treatment for AF, demonstrating superiority over pharmacological therapy in maintaining sinus rhythm and improving prognosis. Numerous studies have indicated that CA can significantly enhance renal function, although the precise mechanisms underlying this improvement remain to be fully elucidated.
文章引用：陈小玲, 李传伟. 导管消融术改善心房颤动患者肾功能受损的研究进展[J]. 临床医学进展, 2024, 14(9): 758-764. https://doi.org/10.12677/acm.2024.1492526

参考文献

[1] Ding, W.Y., Gupta, D., Wong, C.F. and Lip, G.Y.H. (2020) Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease. Cardiovascular Research, 117, 1046-1059. [Google Scholar] [CrossRef] [PubMed]
[2] Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J.J., Blomström-Lundqvist, C., et al. (2020) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 42, 373-498. [Google Scholar] [CrossRef] [PubMed]
[3] Hsieh, Y., Chen, Y., Chien, K., Chung, F., Lo, L., Chang, S., et al. (2020) Catheter Ablation of Atrial Fibrillation Reduces the Risk of Dementia and Hospitalization during a Very Long-Term Follow-Up. International Journal of Cardiology, 304, 75-81. [Google Scholar] [CrossRef] [PubMed]
[4] Sakamoto, K., Tohyama, T., Ide, T., Mukai, Y., Enzan, N., Nagata, T., et al. (2023) Efficacy of Early Catheter Ablation for Atrial Fibrillation after Admission for Heart Failure. JACC: Clinical Electrophysiology, 9, 1948-1959. [Google Scholar] [CrossRef] [PubMed]
[5] Liu, Z., Yang, Z., Lu, Y., Wang, H. and Zou, C. (2023) Short-Term and Long-Term Effects of Cryoballoon Ablation versus Antiarrhythmic Drug Therapy as First-Line Treatment for Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis. Clinical Cardiology, 46, 1146-1153. [Google Scholar] [CrossRef] [PubMed]
[6] Benjamin, E.J., Muntner, P., Alonso, A., Bittencourt, M.S., Callaway, C.W., Carson, A.P., et al. (2019) Heart Disease and Stroke Statistics—2019 Update: A Report from the American Heart Association. Circulation, 139, e56-e528. [Google Scholar] [CrossRef] [PubMed]
[7] Soliman, E.Z., Prineas, R.J., Go, A.S., Xie, D., Lash, J.P., Rahman, M., et al. (2010) Chronic Kidney Disease and Prevalent Atrial Fibrillation: The Chronic Renal Insufficiency Cohort (CRIC). American Heart Journal, 159, 1102-1107. [Google Scholar] [CrossRef] [PubMed]
[8] Baber, U., Howard, V.J., Halperin, J.L., Soliman, E.Z., Zhang, X., McClellan, W., et al. (2011) Association of Chronic Kidney Disease with Atrial Fibrillation among Adults in the United States. Circulation: Arrhythmia and Electrophysiology, 4, 26-32. [Google Scholar] [CrossRef] [PubMed]
[9] Heo, G.Y., Park, J.T., Kim, H.J., Kim, K.W., Kwon, Y.U., Kim, S.H., et al. (2024) Adequacy of Dialysis and Incidence of Atrial Fibrillation in Patients Undergoing Hemodialysis. Circulation: Cardiovascular Quality and Outcomes, 17, e010595. [Google Scholar] [CrossRef] [PubMed]
[10] Alonso, A., Lopez, F.L., Matsushita, K., Loehr, L.R., Agarwal, S.K., Chen, L.Y., et al. (2011) Chronic Kidney Disease Is Associated with the Incidence of Atrial Fibrillation. Circulation, 123, 2946-2953. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, S., Jeong, Y., Kim, Y.L., Kang, M., Kang, E., Ryu, H., et al. (2023) Association of Chronic Kidney Disease with Atrial Fibrillation in the General Adult Population: A Nationwide Population-Based Study. Journal of the American Heart Association, 12, e028496. [Google Scholar] [CrossRef] [PubMed]
[12] Boriani, G., Iacopino, S., Arena, G., Pieragnoli, P., Verlato, R., Manfrin, M., et al. (2022) Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation. Journal of Cardiovascular Development and Disease, 9, Article 126. [Google Scholar] [CrossRef] [PubMed]
[13] Bansal, N., Fan, D., Hsu, C., Ordonez, J.D., Marcus, G.M. and Go, A.S. (2013) Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults with Chronic Kidney Disease. Circulation, 127, 569-574. [Google Scholar] [CrossRef] [PubMed]
[14] Bansal, N., Xie, D., Tao, K., Chen, J., Deo, R., Horwitz, E., et al. (2016) Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical Journal of the American Society of Nephrology, 11, 1189-1196. [Google Scholar] [CrossRef] [PubMed]
[15] Shen, Y., Wang, J., Chen, H., Li, M. and Chen, M. (2020) Factors Associated with Renal Impairment in Chinese Patients with Non-Valvular AF and without an Established Renal Disease: A Cross-Sectional Study. Postgraduate Medicine, 132, 452-457. [Google Scholar] [CrossRef] [PubMed]
[16] Song, J., Navarro-Garcia, J.A., Wu, J., Saljic, A., Abu-Taha, I., Li, L., et al. (2023) Chronic Kidney Disease Promotes Atrial Fibrillation via Inflammasome Pathway Activation. Journal of Clinical Investigation, 133, e167517. [Google Scholar] [CrossRef] [PubMed]
[17] Sahinoz, M. and Ikizler, T.A. (2024) Inflammasome Activation: Unraveling the Link between Chronic Kidney Disease and Atrial Fibrillation. Kidney International, 106, 6-9. [Google Scholar] [CrossRef] [PubMed]
[18] Mascolo, A., Urbanek, K., De Angelis, A., Sessa, M., Scavone, C., Berrino, L., et al. (2019) Angiotensin II and Angiotensin 1-7: Which Is Their Role in Atrial Fibrillation? Heart Failure Reviews, 25, 367-380. [Google Scholar] [CrossRef] [PubMed]
[19] Ames, M.K., Atkins, C.E. and Pitt, B. (2019) The Renin-Angiotensin-Aldosterone System and Its Suppression. Journal of Veterinary Internal Medicine, 33, 363-382. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, W., Chen, Y., Hsieh, M., Huang, S., Kao, Y., Chen, Y., et al. (2014) The Uremic Toxin Indoxyl Sulfate Increases Pulmonary Vein and Atrial Arrhythmogenesis. Journal of Cardiovascular Electrophysiology, 26, 203-210. [Google Scholar] [CrossRef] [PubMed]
[21] Heijman, J. and Dobrev, D. (2022) Determinants and Therapeutic Potential of Calcium Handling Abnormalities in Atrial Fibrillation: What Can We Learn from Computer Models? The Journal of Physiology, 601, 2545-2546. [Google Scholar] [CrossRef] [PubMed]
[22] Yamagami, F., Tajiri, K., Yumino, D. and Ieda, M. (2019) Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications. Toxins, 11, Article 597. [Google Scholar] [CrossRef] [PubMed]
[23] Ternacle, J., Côté, N., Krapf, L., Nguyen, A., Clavel, M. and Pibarot, P. (2019) Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease. Canadian Journal of Cardiology, 35, 1195-1207. [Google Scholar] [CrossRef] [PubMed]
[24] Zakrocka, I. and Załuska, W. (2022) Anticoagulant-Related Nephropathy: Focus on Novel Agents: A Review. Advances in Clinical and Experimental Medicine, 31, 165-173. [Google Scholar] [CrossRef] [PubMed]
[25] Arnson, Y., Hoshen, M., Berliner-Sendrey, A., Reges, O., Balicer, R., Leibowitz, M., et al. (2020) Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease. Cardiology, 145, 178-186. [Google Scholar] [CrossRef] [PubMed]
[26] Deng, H., Shantsila, A., Xue, Y., Bai, Y., Guo, P., Potpara, T.S., et al. (2019) Renal Function and Outcomes after Catheter Ablation of Patients with Atrial Fibrillation: The Guangzhou Atrial Fibrillation Ablation Registry. Archives of Cardiovascular Diseases, 112, 420-429. [Google Scholar] [CrossRef] [PubMed]
[27] Yanagisawa, S., Inden, Y., Kato, H., Fujii, A., Mizutani, Y., Ito, T., et al. (2017) Impaired Renal Function Is Associated with Recurrence after Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: A Potential Effect of Non-Pulmonary Vein Foci. Journal of Cardiology, 69, 3-10. [Google Scholar] [CrossRef] [PubMed]
[28] Lee, W., Wu, P., Fang, C., Chen, H. and Chen, M. (2021) Impact of Chronic Kidney Disease on Atrial Fibrillation Recurrence Following Radiofrequency and Cryoballoon Ablation: A Meta-Analysis. International Journal of Clinical Practice, 75, e14173. [Google Scholar] [CrossRef] [PubMed]
[29] Vitali, F., Serenelli, M., Airaksinen, J., Pavasini, R., Tomaszuk-Kazberuk, A., Mlodawska, E., et al. (2019) CHA2DS2-VASc Score Predicts Atrial Fibrillation Recurrence after Cardioversion: Systematic Review and Individual Patient Pooled Meta-Analysis. Clinical Cardiology, 42, 358-364. [Google Scholar] [CrossRef] [PubMed]
[30] Ichijo, S., Miyazaki, S., Kusa, S., Nakamura, H., Hachiya, H., Kajiyama, T., et al. (2018) Impact of Catheter Ablation of Atrial Fibrillation on Long-Term Clinical Outcomes in Patients with Heart Failure. Journal of Cardiology, 72, 240-246. [Google Scholar] [CrossRef] [PubMed]
[31] Friberg, L., Tabrizi, F. and Englund, A. (2016) Catheter Ablation for Atrial Fibrillation Is Associated with Lower Incidence of Stroke and Death: Data from Swedish Health Registries. European Heart Journal, 37, 2478-2487. [Google Scholar] [CrossRef] [PubMed]
[32] Ullal, A.J., Kaiser, D.W., Fan, J., Schmitt, S.K., Than, C.T., Winkelmayer, W.C., et al. (2016) Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients with Chronic Kidney Disease. Journal of Cardiovascular Electrophysiology, 28, 39-48. [Google Scholar] [CrossRef] [PubMed]
[33] Aoyama, D., Uzui, H., Sekihara, T., Eguchi, T., Hasegawa, K., Tsuji, T., et al. (2022) Declines in Serum Uric Acid Level after Catheter Ablation of Atrial Fibrillation. Heart and Vessels, 37, 2049-2058. [Google Scholar] [CrossRef] [PubMed]
[34] Okawa, K., Miyoshi, T., Sogo, M., Hara, S., Sudo, Y., Ugawa, S., et al. (2020) Improvement in Renal and Endothelial Function after Catheter Ablation in Patients with Persistent Atrial Fibrillation. Journal of Cardiology, 76, 610-617. [Google Scholar] [CrossRef] [PubMed]
[35] Navaravong, L., Barakat, M., Burgon, N., Mahnkopf, C., Koopmann, M., Ranjan, R., et al. (2014) Improvement in Estimated Glomerular Filtration Rate in Patients with Chronic Kidney Disease Undergoing Catheter Ablation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 26, 21-27. [Google Scholar] [CrossRef] [PubMed]
[36] Diaz, C.L., Kaplan, R.M., Peigh, G., Bavishi, A., Baman, J.R., Trivedi, A., et al. (2020) Improvement in Renal Function Following Cryoballoon Ablation for Atrial Fibrillation. Journal of Interventional Cardiac Electrophysiology, 60, 513-520. [Google Scholar] [CrossRef] [PubMed]
[37] Shen, Y., Chen, H., Yang, G., Ju, W., Zhang, F., Gu, K., et al. (2022) Changes in Renal Function in Patients with Recurrence of Atrial Arrhythmia after an Initial Catheter Ablation. International Journal of Clinical Practice, 2022, 1-8. [Google Scholar] [CrossRef] [PubMed]
[38] Mimuro, R., Hayashi, H., Iwasaki, Y., Hachisuka, M., Fujimoto, Y., Oka, E., et al. (2022) Protective Effect of Catheter Ablation of Atrial Fibrillation on the Renal Function in Patients with Hypertrophic Cardiomyopathy. The American Journal of Cardiology, 173, 8-15. [Google Scholar] [CrossRef] [PubMed]
[39] Park, J., Yang, P., Bae, H., Yang, S., Yu, H.T., Kim, T., et al. (2019) Five-Year Change in the Renal Function after Catheter Ablation of Atrial Fibrillation. Journal of the American Heart Association, 8, e013204. [Google Scholar] [CrossRef] [PubMed]
[40] Kovačević, V., Marinković, M.M., Kocijančić, A., Isailović, N., Simić, J., Mihajlović, M., et al. (2023) Long-Term Renal Function after Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Development and Disease, 10, Article 151. [Google Scholar] [CrossRef] [PubMed]
[41] Tokuda, M., Yamane, T., Matsuo, S., Ito, K., Narui, R., Hioki, M., et al. (2010) Relationship between Renal Function and the Risk of Recurrent Atrial Fibrillation Following Catheter Ablation. Heart, 97, 137-142. [Google Scholar] [CrossRef] [PubMed]

为你推荐